ANDA 88755, held by Watson Labs. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 88755 (Thioridazine Hydrochloride), held by Watson Labs, was first approved by FDA on Jul 24, 1984, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 24, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride25MG ยท tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Jan 7, 1991 | Supplement 5Labeling | Approved | None posted |
| Jul 24, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters